PHARMAC - Latest News [Page 24]
PHARMAC seeks best deal for NZers through tender
Monday, 15 January 2007, 9:39 am | PHARMAC
PHARMAC is continuing to secure the best possible value for the health dollar with the release of the latest tender round. The Government drug funding agency is tendering for supply of 249 different medicines used in both hospitals and the community. More >>
More Treatment Options For People With Bipolar
Tuesday, 9 January 2007, 2:20 pm | PHARMAC
People with bipolar disorder will benefit from a PHARMAC decision to widen access to a medicine already used to treat epilepsy. More >>
Four into one for new HIV TREATMENT
Thursday, 21 December 2006, 12:05 am | PHARMAC
People taking four tablets a day for HIV will soon only need to take one, following a funding decision by PHARMAC More >>
PHARMAC seeking feedback on High Cost Medicines
Monday, 18 December 2006, 2:23 pm | PHARMAC
PHARMAC is seeking public submissions on a review of how high cost medicines are assessed and funded. More >>
Making best use of medicines a key challenge
Tuesday, 28 November 2006, 4:20 pm | PHARMAC
PHARMAC is giving New Zealanders a “could do better” for the way they use medicine. Figures released in PHARMAC’s 2006 Annual Review show that prescriptions for subsidised medicine have reached an all-time high of 28.5 million prescriptions, independent ... More >>
Improving health literacy key to improving health
Tuesday, 28 November 2006, 1:34 pm | PHARMAC
There are few things more powerful than a well-informed patient, and an improvement in `health literacy’ is likely to significantly improve health results for New Zealanders, says PHARMAC’s Medical Director Dr Peter Moodie. More >>
PHARMAC achieves excellent result in 2006
Friday, 10 November 2006, 4:53 pm | PHARMAC
A huge jump in the number of people receiving subsidised medicines and a record number of prescriptions are recorded in PHARMAC’s 2006 Annual Report. More >>
HIV treatment takes two steps forward
Wednesday, 1 November 2006, 11:13 am | PHARMAC
A once-a-day medicine to attack the HIV/AIDS virus is part of a package of treatments for people with HIV announced by Pharmac today. Atazanavir (Reyataz) is a once a day HIV protease inhibitor which has the advantage of having fewer metabolic side ... More >>
Herceptin status unchanged
Monday, 16 October 2006, 11:59 am | PHARMAC
Herceptin is to remain unfunded for early stage breast cancer for the present time, PHARMAC said today. More >>
PHARMAC To Fund Prader-Willi Growth Hormone
Tuesday, 3 October 2006, 3:00 pm | PHARMAC
A growth hormone that enhances the lives of children with Prader-Willi syndrome is now fully funded. More >>
Brand change for ADHD medication
Friday, 29 September 2006, 3:57 pm | PHARMAC
New Zealanders taking long-acting methylphenidate – mostly children with the behavioural condition Attention Deficit Hyperactivity Disorder (ADHD) – will see a change in the brand of their medication from 1 November. More >>
PHARMAC to fund medicine for acute heart patients
Thursday, 28 September 2006, 3:08 pm | PHARMAC
From 1 October 2006, people with acute heart problems will benefit from a decision by PHARMAC to subsidise clopidogrel, a drug that helps prevent blood clots developing in arteries. More >>
Breast cancer treatments get a funding boost
Thursday, 31 August 2006, 3:43 pm | PHARMAC
Treatments for early breast cancer are getting a boost with a decision to fund the taxane drug paclitaxel for early breast cancer. More >>
New weapon for battle against HIV/AIDS
Thursday, 24 August 2006, 4:06 pm | PHARMAC
The first of a new type of drugs to treat HIV/AIDS will be funded for New Zealanders from next month. More >>
Further Herceptin information received by PTAC
Thursday, 17 August 2006, 4:39 pm | PHARMAC
PHARMAC’s clinical advisory committee PTAC today considered further information on the use of Herceptin for early breast cancer. More >>
PHARMAC: Herceptin - Questions and answers
Friday, 28 July 2006, 3:50 pm | PHARMAC
Why is Herceptin not yet funded in NZ? The evidence on Herceptin is not yet strong enough to enable PHARMAC to make a positive funding decision on Herceptin. PHARMAC remains open to funding the drug and will be continuously reviewing further evidence ... More >>
Herceptin not funded, under continuing review
Friday, 28 July 2006, 1:41 pm | PHARMAC
Funding has not yet been approved for breast cancer drug Herceptin, but will be kept under review by Government drug-funding agency PHARMAC as new information emerges. More >>
Asthma inhaler range gets a positive shake-up
Wednesday, 26 July 2006, 11:09 am | PHARMAC
Subsidies for asthma inhalers will get a big shake-up from 1 August. More people will be able to have long-acting inhalers, such as Oxis and Serevent, because of relaxed prescribing rules which see Special Authorities removed. More >>
Obesity epidemic fuels worrying diabetes trends
Tuesday, 4 July 2006, 9:29 am | PHARMAC
The obesity epidemic is behind a disturbing rise in diabetes in New Zealand, with this age-related disease now increasingly hitting teenagers. More >>
Antibiotics secured for influenza pandemic
Monday, 26 June 2006, 2:52 pm | PHARMAC
New Zealanders will have access to a secure supply of antibiotics for use during an influenza pandemic. More >>
